Veritas Pharma Inc.

Recent News

  • Veritas Signs Letter of Intent to Acquire Indigenous Bloom Hemp Corporation

    Vancouver, British Columbia--(Newsfile Corp. - May 22, 2020) - Veritas Pharma Inc.'s (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") is pleased to announce that on May 14th, 2020, the company entered into a Letter of Intent ("LOI") to acquire Indigenous Bloom Hemp Corporation ("HempCo").HempCo operates a...

    2020-05-22 4:05 PM ET
  • Veritas Pharma Announces Corrections to Financial Disclosures

    Vancouver, British Columbia--(Newsfile Corp. - May 21, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announce that as a result of a review of its continuous disclosures record by the British Columbia Securities Commission ("BCSC") on May 20th, 2020, the...

    2020-05-21 6:40 PM ET
  • Veritas Pharma Announces Granting of Stock Options

    Vancouver, British Columbia--(Newsfile Corp. - April 27, 2020) -  Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") wishes to announce that it has issued 1,215,789 options to directors and officers of the Company under the stock option plan at an exercise price of...

    2020-04-27 4:30 PM ET
  • Veritas Pharma Announces New Appointments to the Board of Directors

    Vancouver, British Columbia--(Newsfile Corp. - April 24, 2020) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VPA) ("Veritas" or the "Company") wishes to announce that it has appointed Lorne Mark Roseborough as Chairman of the Board. The Company also wishes to announce the appointment of Sharon Blady...

    2020-04-24 4:15 PM ET
  • Veritas Pharma Announces Preliminary Clinical Trial Results and the Company's New Direction

    Vancouver, British Columbia--(Newsfile Corp. - February 13, 2020) -  Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the Company's new strategy going forward.Preliminary Results of Clinical TrialsThe...

    2020-02-13 6:15 PM ET
  • Veritas Announces the Sale of the Sechelt Property

    Vancouver, British Columbia--(Newsfile Corp. - December 9, 2019) - Veritas Pharma Inc.'s (CSE: VRT) (OTC: VRTHF) (Frankfurt: 2VP) ("Veritas" or the "Company") is pleased to announce that its fully owned subsidiary the Sechelt Organic Marijuana Corp. has completed the sale of its property located in Sechelt, BC, to Lis Holdings...

    2019-12-09 8:45 AM ET
  • Veritas' Proceeding to Build State-of-the-Art Cannabis Cultivation Facility

    Vancouver, British Columbia--(Newsfile Corp. - July 10, 2017) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (Frankfurt: 2VP) is pleased to announce that it is preparing to begin construction of a state-of-the-art cannabis growing facility upon receiving Health Canada's license under Access to Cannabis for Medical Purposes Regulations (ACMPR). Veritas...

    2017-07-10 5:08 AM ET
  • Veritas Pharma Places Final Payment in Trust for the Acquisition of Cannevert Therapeutics

    Vancouver, British Columbia--(Newsfile Corp. - January 25, 2017) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), an emerging discovery and IP development company, has announced that it has placed its final payment of $250,000 to Cannevert Therapeutics Ltd. (CTL) (scheduled for May 1st, 2017) into a trust...

    2017-01-25 6:23 PM ET